Real estate
The former Pfizer campus in New York’s Hudson Valley owned by Industrial Realty Group has gained a new tenant.
Nephron Pharma is rapidly expanding its presence in the area with a $12.5M investment to expand its manufacturing facility and create 125 new jobs.
The company has snapped up manufacturing space in North Carolina’s Research Triangle Park to internally produce lentiviral vector for the company’s gene and cell therapies.
Clovis Oncology has solidified its physical footprint in the Bay Area with a 32,000 square foot space it secured for 10 years through property developer TMG Partners.
Gritstone Oncology is hanging a “help wanted” sign as the company looks to staff a new 43,000 square-foot manufacturing facility in Pleasanton, Calif. that will be the center of the company’s immunotherapy manufacturing efforts.
J&J is balking at a plan to build a site in Britain due to concerns over the economy.
The company announced that Neutrolis and Remora Therapeutics are the winners of Bristol-Myers Squibb’s 2017 Golden Tickets for LabCentral.
Fresenius Kabi will invest $100M in eastern North Carolina as it expands its current production facility and prepares to build a new onsite manufacturing center.
Less than one week after the FDA cleared Innovative Health Solutions’ NSS-2 Bridge, the company announced it will expand its payroll to include a number of new businesses.
Pharma and biotech stakeholders applauded the vote as Amsterdam achieved the hightest rate of acceptance of the EMA staff for relocatation, according to a survey.
PRESS RELEASES